Overview
Marie-emilie Dourthe practices practicing medicine in Paris, France.
Dourthe is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Classical Hodgkin Lymphoma, and Hodgkin Lymphoma.
They are actively involved in clinical research, co-authoring 33 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marie-emilie E. Dourthe
Is Marie-emilie E. Dourthe a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?
MediFind is an objective health platform that identifies experts based on real-world data. Marie-emilie E. Dourthe is classified as an Advanced expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marie-emilie E. Dourthe participate in research or clinical trials?
Yes. Marie-emilie E. Dourthe has published 33 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Marie-emilie E. Dourthe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- LeukemiaDourthe isAdvanced. Learn about Leukemia.
- Experienced
- Adult T-Cell LeukemiaDourthe isExperienced. Learn about Adult T-Cell Leukemia.
- Anaplastic Large Cell LymphomaDourthe isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Burkitt LymphomaDourthe isExperienced. Learn about Burkitt Lymphoma.
- Classical Hodgkin LymphomaDourthe isExperienced. Learn about Classical Hodgkin Lymphoma.
- Embryonal Tumor with Multilayered Rosettes
- Follicular LymphomaDourthe isExperienced. Learn about Follicular Lymphoma.
- Gliomatosis CerebriDourthe isExperienced. Learn about Gliomatosis Cerebri.
- Hepatitis ADourthe isExperienced. Learn about Hepatitis A.
- Hodgkin LymphomaDourthe isExperienced. Learn about Hodgkin Lymphoma.
- Juvenile Myelomonocytic Leukemia (JMML)
- Nasopharyngeal CarcinomaDourthe isExperienced. Learn about Nasopharyngeal Carcinoma.
- NeuroblastomaDourthe isExperienced. Learn about Neuroblastoma.
- Neurotoxicity SyndromesDourthe isExperienced. Learn about Neurotoxicity Syndromes.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Non-Hodgkin LymphomaDourthe isExperienced. Learn about Non-Hodgkin Lymphoma.